TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,726.85+0.88%Nasdaq 10029,774.02+2.01%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$219.18+2.36%NYSE:TSM$425.48+3.12%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,141.11−0.58%Brent$108.75−0.97%BTC$81,895.50−0.14%ETH$2,392.61−0.61%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,726.85+0.88%Nasdaq 10029,774.02+2.01%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$219.18+2.36%NYSE:TSM$425.48+3.12%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,141.11−0.58%Brent$108.75−0.97%BTC$81,895.50−0.14%ETH$2,392.61−0.61%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Vertex Pharmaceuticals Inc · Overview · TradingHolo

Markets › United States › NAS › VRTX

V

Vertex Pharmaceuticals Inc

NAS:VRTXHealthcareNASDAQ:NBINASDAQ:NQUSLG

$499.74−1.77%At closeAt close · Sat 17 Oct · ≈ AED 1,835.30 · Market cap $126.66B · Next earnings Mon 2 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−1.8%

1M

−3.2%

3M

+4.0%

6M

+13.3%

1Y

+22.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

VRTX −1.77% today

✦ This week in three lines

No written digest yet for VRTX. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +14.2%

Valuation

P/E vs sector32.0× vs −1.7×

Price / Book vs sector6.8× vs 2.0×

Price / Sales vs sector10.5× vs 3.9×

Price / Free cash flow vs sector39.7× vs −1.6×

cheap for itself (22.7×)expensive for itself (30.3×)

Forecasts

27 buy7 hold1 sell35 analysts

Average target$555.57 +11.2%

Analysts7

EPS surprises, last 84 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All VRTX news →

SENotable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus

Seeking Alpha · 27 h ago

TRVertex Pharmaceuticals Incorporated (VRTX) Reports Interim ALYFTREK Data in 2–5 Year-Olds

TradingView · 10 d ago

BUVertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference

BusinessWire · 10 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$126.66B

P/E32.0×

Dividend yield0.0%

52-week range$403.16 – $560.25

Avg volume (20d)1,168,558

Shares outstanding253,461,000

Beta0.30

Short interest1.8% of float

Next earningsMon 2 Nov

Radar Score

63

Value43

Quality92

Momentum71

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%